Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase I pharmacokinetic study of NATESTO testosterone nasal gel in male patients with seasonal allergic rhinitis

Next Previous
X
Search
Trial Profile

A phase I pharmacokinetic study of NATESTO testosterone nasal gel in male patients with seasonal allergic rhinitis

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 20 Apr 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Testosterone (Primary)
  • Indications Hypogonadism
  • Focus Pharmacokinetics

    • Most Recent Events

    • 04 Apr 2017 Results from this and NCT01446042 study investigating the impact of seasonal allergies on absorption of Natesto nasal gel in hypogonadal men, presented at The 99th Annual Meeting of the Endocrine Society.
    • 07 Jul 2016 New trial record
    • 17 Jun 2016 Results published in an Acerus Pharmaceuticals Corporation media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top